Hydrogels includes dressings that consist of 96% water with a matrix of insoluble polymers embedded in it. The Medical Devices sector report, “Hydrogels Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Hydrogels pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The data and analysis within this report are driven by the Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
The Hydrogels report provides key information and data related to:
- Extensive coverage of the Hydrogels under development
- Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
- Reviews of major players involved in the pipeline product development.
- Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Hydrogels pipeline products.
- Review of Recent Developments in the segment/industry
The Hydrogels report enables you to:
- Access significant competitor information, analysis, and insights to improve your R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Hydrogels under development
- Formulate market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
The Publisher's Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.The data and analysis within this report are driven by the Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
- 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
- 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
- 64,000+ medical equipment company profiles
- 5,600+ company profiles of medical equipment manufacturers in China and India
- 2,200+ company profiles of medical equipment manufacturers in Japan
- 1,200+ companies’ revenue splits and market shares
- 1,600+ quarterly and annual medical equipment company financials
- 850+ medical equipment company SWOTs
- 28,000+ pipeline product profiles
- 56,400+ marketed product profiles
- 47,000+ clinical trials
- 41,500+ trial investigators
- 7,000+ reports on companies with products in development
- 44,000+ deals in the medical equipment industry
- 1,100+ surgical and diagnostic procedures by therapy area
- 50+ key healthcare indicators by country
- 431,000+ Themes Content Items
- 600+ Influencers
- 1,900+ Analysts & Researchers
- 0.5m+ Community Members
- 141,000+ Macroeconomic Indicators
- 1,013,000+ City Indicators
Scope
- Extensive coverage of the Hydrogels under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hydrogels and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to -- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Hydrogels under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Hydrogels - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3QMatrix, Inc. (Inactive)
- Abeona Therapeutics Inc
- AgeX Therapeutics Inc
- Alafair Biosciences Inc
- Albert Ludwigs University of Freiburg
- Amend Surgical, Inc.
- Angiotech Pharmaceuticals Inc
- AXXO Im- und Export GmbH
- BioCure Inc
- Biomendics LLC
- Brigham and Women's Hospital
- CelaCare Technologies LLC
- Ceramicos Para Aplicacoes Medicas SA
- Chi2Gel Ltd.
- CorMedix Inc
- Drexel University
- Edixomed Ltd
- Exogenus Therapeutics SA
- Flexion Therapeutics Inc
- Gel4Med Inc
- Gelesis Inc
- GelSana Therapeutics Inc
- HyperBranch Medical Technology Inc
- Icahn School of Medicine at Mount Sinai
- In2cure AB
- Indian Institute of Technology, Kanpur
- Institute of Nano Science and Technology
- Ionic Pharmaceuticals LLC
- IPI Singapore
- Jenarron Therapeutics Ltd
- Johns Hopkins University
- Kane Biotech Inc
- Keratin Biosciences Inc
- Magle Chemoswed AB
- McMaster University
- Missouri University of Science and Technology
- Neotherix Ltd
- Northwestern University
- Novyx Technologies LLC
- O2 Regentech LLC
- Ohio State University
- Orla Protein Technologies Ltd
- Piramal Enterprises Ltd
- Plurogen Therapeutics Inc (Inactive)
- Queensland University of Technology
- Quick-Med Technologies Inc
- Quthero Inc
- Regentys Corp
- Scarless Laboratories Inc
- SolasCure Ltd
- Sonoma Pharmaceuticals Inc
- Spanish National Research Council
- Squid Healthcare Inc
- Stanford University
- Sunogel Biotechnologies Inc
- SynDermix AG
- Syracuse Biolabs Inc
- Syracuse University
- Tectum
- Tel Aviv Sourasky Medical Center
- Tel Aviv University
- Texas Medical Center
- Tokyo University of Science
- University of California San Diego
- University of Florida
- University of Illinois at Chicago
- University of Pennsylvania
- University of Queensland
- University of Wisconsin Madison
- Ventrix Inc
- VTT Technical Research Centre of Finland Ltd
- Washington University in St Louis
- Zeomedix, LLC